Dan Theodorescu MD, PhD
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Y Gui, G Guo, Y Huang, X Hu, A Tang, S Gao, R Wu, C Chen, X Li, L Zhou, ...
Nature genetics 43 (9), 875-878, 2011
A community effort to assess and improve drug sensitivity prediction algorithms
JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...
Nature biotechnology 32 (12), 1202-1212, 2014
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis
D Theodorescu, S Wittke, MM Ross, M Walden, M Conaway, I Just, ...
The lancet oncology 7 (3), 230-240, 2006
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ...
Molecular & cellular proteomics 9 (11), 2424-2437, 2010
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
G Guo, X Sun, C Chen, S Wu, P Huang, Z Li, M Dean, Y Huang, W Jia, ...
Nature genetics 45 (12), 1459-1463, 2013
Metastasis: a therapeutic target for cancer
PS Steeg, D Theodorescu
Nature clinical practice Oncology 5 (4), 206-219, 2008
Clinical proteomics: a need to define the field and to begin to set adequate standards
H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ...
PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007
A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery
JK Lee, DM Havaleshko, HJ Cho, JN Weinstein, EP Kaldjian, J Karpovich, ...
Proceedings of the National Academy of Sciences 104 (32), 13086-13091, 2007
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer
JJ Gildea, MJ Seraj, G Oxford, MA Harding, GM Hampton, CA Moskaluk, ...
Cancer research 62 (22), 6418-6423, 2002
The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations
Y Ru, KJ Kechris, B Tabakoff, P Hoffman, RA Radcliffe, R Bowler, ...
Nucleic acids research 42 (17), e133-e133, 2014
Recommendations for biomarker identification and qualification in clinical proteomics
H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ...
Science translational medicine 2 (46), 46ps42-46ps42, 2010
TERT promoter mutations and telomerase reactivation in urothelial cancer
S Borah, L Xi, AJ Zaug, NM Powell, GM Dancik, SB Cohen, JC Costello, ...
Science 347 (6225), 1006-1010, 2015
Cancer incidence after localized therapy for prostate cancer
K Moon, GJ Stukenborg, J Keim, D Theodorescu
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.
I Cornil, D Theodorescu, S Man, M Herlyn, J Jambrosic, RS Kerbel
Proceedings of the National Academy of Sciences 88 (14), 6028-6032, 1991
Cellular Disposal of miR23b by RAB27-Dependent Exosome Release Is Linked to Acquisition of Metastatic PropertiesExosome miRNAs in Bladder Cancer Metastasis
MS Ostenfeld, DK Jeppesen, JR Laurberg, AT Boysen, JB Bramsen, ...
Cancer research 74 (20), 5758-5771, 2014
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
DS Im, CE Heise, MA Harding, SR George, BF O'Dowd, D Theodorescu, ...
Molecular pharmacology 57 (4), 753-759, 2000
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer
DM Smalley, NE Sheman, K Nelson, D Theodorescu
Journal of proteome research 7 (5), 2088-2096, 2008
CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
JJ Coon, P Zürbig, M Dakna, AF Dominiczak, S Decramer, D Fliser, ...
Proteomics–Clinical Applications 2 (7‐8), 964-973, 2008
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20